Boston Scientific · 19 hours ago
Software Engineer III
Maple Grove, MN
Full-time
Hybrid
Entry, Mid Level
$78K/yr - $149K/yr
2+ years expBoston Scientific is a leader in medical science dedicated to solving important health industry challenges. They are seeking a Software Engineer III who will be accountable for delivering innovative software medical device applications, significantly impacting patient therapies. The role involves leadership, application development, project support, and strategic business growth.
Health CareMedicalMedical Device
No H1B
Responsibilities
Leadership - strategies for creating high performing teams, establish team goals to support business goals, team mentoring, hiring, team career planning, performance management, and retention
Application Development - application of appropriate development methodologies, establishing software estimating practices, specifying application development environments and toolchains for Continuous Integration and Continuous Deployment
Project Support - designating project software leads, allocating engineering resources to projects, specifying and monitoring metrics for executing to plan
Communication – institute efficient practices for communicating with: Senior Staff, direct reports, and cross-functional collaborators; Marketing, Project Management, Regulatory, and Quality Assurance
Grow the Business – establish a strategic team structure to allow the business to scale with additional software products, contribute to product innovations, identify, and implement tactical continuous improvement, buy versus develop tradeoffs, technology evaluation, industry networking and developing accretive partnerships
Qualification
Required
Bachelor's degree or the equivalent combination of education and experience required
2 – 4 years of relevant experience
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Leadership Team
Michael Mahoney
Chairman, President & CEO
Daniel J. Brennan
Chief Financial Officer
Recent News
2026-01-22
Company data provided by crunchbase